References
- Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Investig 2013;123:996–1002
- Amore M, Di Donato P, Berti A, et al. Sexual and psychological symptoms in the climacteric years. Maturitas 2007;6:303–11
- Dosi R, Bhatt N, Shah P, Patell R. Cardiovascular disease and menopause. J Clin Diagnos Res 2014;8:62–4
- Moilanen JM, Aalto AM, Raitanen J, et al. Physical activity and change in quality of life during menopause – an 8-year follow-up study. Health Qual Life Outcome 2012;10:1–7
- Sturdee DW, Pines A. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20
- Gallagher JC. Effect of early menopause on bone mineral density and fractures. Menopause 2007;14:567–71
- Finch CE. The menopause and aging, a comparative perspective. J Stero Biochem Mol Biol 2014;142:132–41
- Bonetti D, Martina M, Falcettoni M, Longhese M. Telomere-end processing: mechanisms and regulation. Chromosoma 2014;123:57–66
- Sfeir AJ, Chai W, Shay JW, Wright WE. Telomere end processing: the terminal nucleotides of human chromosomes. Mol Cell 2005;18:131–8
- Bernardes de Jesus B, Blasco MA. Telomerase at the intersection of cancer and aging. Trends Genetics 2013;29:513–20
- Bernardes de Jesus B, Blasco MA. Telomerase at the intersection of cancer and aging. Trends Genetics 2013;29:513–20
- Lucia Carulli, Claudia Anzivino. Telomere and telomerase in chronic liver disease and hepatocarcinoma. World J Gastroenterol 2014;20:6287–92
- Bernardes de Jesus B, Elsa Vera, Kerstin Schneebergeret, et al. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer. EMBO Mol Med 2012;4:1–14
- Hathcock KS, Jeffrey CY, Hodes RJ. In vivo regulation of telomerase activity and telomere length. Immunol Rev 2005;205:104–13
- Xi H, Li C, Ren F, et al. Telomere, aging and age-related diseases. Age Clin Exp Res 2013;25:139–46
- Cha Y, Kwon SJ, Seol W, Park KS. Estrogen receptor-alpha mediates the effects of estradiol on telomerase activity in human mesenchymal stem cells. Mol Cells 2008;26:454–8
- Soerensen M, Thinggaard M, Nygaard M, et al. Genetic variation in TERT and TERC and human leukocyte telomere length and longevity: a cross-sectional and longitudinal analysis. Aging Cell 2012;11:223–7
- Kyo S1, Takakura M, Kanaya T, et al. Estrogen activates telomerase. Cancer Res 1999;59:5917–21
- Suzuki T, Abe K, Inoue A, Aoki F. Expression of c-MYC in nuclear speckles during mouse oocyte growth and preimplantation development. J Reprod Dev 2009;55:49–95
- Zhou C, Steplowski TA, Dickens HK, et al. Estrogen induction of telomerase activity through regulation of the mitogen-activated protein kinase (MAPK) dependent pathway in human endometrial cancer cells. PLoS One 2013;8:30–40
- Gladych M, Wojtyla A, Rubis B. Human telomerase expression regulation. Biochem Cell Biol 2011;89:359–76
- Oeseburg H, de Boer RA, van Gilst WH, van der Harst P. Telomere biology in healthy aging and disease. Pflügers Archiv-Eur J Physiol 2010;459:259–68
- Cui J, Shen Y, Li R. Estrogen synthesis and signaling pathways during aging: from periphery to brain. Trends Mol Med 2013;19:197–209
- Hathcock KS, Jeffrey Chiang Y, Hodes RJ. In vivo regulation of telomerase activity and telomere length. Immunol Rev 2005;205:104–13
- Blasco MA. Telomeres in cancer and aging: lessons from the mouse. Cancer Lett 2003;194:183–8
- Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349–52
- Imanishi T, Hano T, Nishio I. Estrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity. J Hypertens 2005;23:1699–706